Disease-modifying vs symptomatic treatments: Splitting over lumping.

Duque, Kevin R; Vizcarra, Joaquin A; Hill, Emily J; Espay, Alberto J

Duque, Kevin R; Vizcarra, Joaquin A; Hill, Emily J; Espay, Alberto J.

Afiliación

Duque KR; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, United States.
Vizcarra JA; Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States.
Hill EJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, United States.
Espay AJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, United States. Electronic address: alberto.espay@uc.edu.

Handb Clin Neurol ; 193: 187-209, 2023.

Article en En | MEDLINE | ID: mdl-36803811

Asunto(s)

Enfermedad de Alzheimer; Enfermedad de Parkinson; Humanos; Enfermedad de Parkinson/genética; Enfermedad de Alzheimer/terapia; Biomarcadores; Envejecimiento

Palabras clave

Alzheimer's disease; Clinical trials; Disease modification; Parkinson's disease; Precision medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Handb Clin Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google